Skip to main content
. 2020 Jul;23(7):841–848. doi: 10.22038/IJBMS.2020.35977.8563

Table 2.

The regional prevalence of MYO15A mutations in GJB2 negative ARNSHL patients

Country Frequency of MYO15A mutations (%)
Brazil 52
Oman 30
Korea 10.5
Algeria 10
Mexico 7.5
Puerto Rico 7.5
Vietnam 7.2
Germany 7.1
Iran 5.8
Banglaka 5
Pakistan 4.9
Taiwan 4.8
Palestin 4.7
China 4.7
Turkey 4.4
United States 3.8
Israel 3.7
India 3.6
Europe 3.1
Moroccan 3
Tunisia 2.3
Spain 2.2
South Africa 2
Nigeria 2
Guatemala 2
Japan 2